Cargando…

Can we stop AIDS with antiretroviral-based treatment as prevention?

Challenges to scaling up treatment as prevention (TasP) of HIV transmission are considerable in the developing-world context and include accessing at-risk populations, human resource shortages, adherence and retention in care, access to newer treatments, measurement of treatment effects, and long-te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Edward J, Nachega, Jean B, Ford, Nathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Global Health: Science and Practice 2013
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168559/ https://www.ncbi.nlm.nih.gov/pubmed/25276515 http://dx.doi.org/10.9745/GHSP-D-12-00053

Ejemplares similares

The first decade of antiretroviral therapy in Africa
por: Ford, Nathan, et al.
Publicado: (2011)

All bleeding stops: how we can help...
por: Riordan, William P, et al.
Publicado: (2010)

Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa
por: Mills, Edward J., et al.
Publicado: (2013)

Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?
por: Vitoria, Marco, et al.
Publicado: (2016)

Use of peers to improve adherence to antiretroviral therapy: a global network meta-analysis
por: Kanters, Steve, et al.
Publicado: (2016)

Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda
por: Mills, Edward J, et al.
Publicado: (2011)

Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda
por: Bakanda, Celestin, et al.
Publicado: (2011)

The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?
por: Russell, Jill, et al.
Publicado: (2020)

Monocyte HLA-DR in sepsis: shall we stop following the flow?
por: Monneret, Guillaume, et al.
Publicado: (2014)

Highly active antiretroviral treatment for the prevention of HIV transmission
por: Granich, Reuben, et al.
Publicado: (2010)

Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
por: Hoffer, Edward P.
Publicado: (2021)

Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis
por: Shubber, Zara, et al.
Publicado: (2016)

Safety of Tenofovir Disoproxil Fumarate–Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis
por: Nachega, Jean B., et al.
Publicado: (2017)

Commentary: Hyperlactatemia after cardiac surgery: Yes we know it is bad but can we reliably prevent and treat it?
por: Omer, Shuab
Publicado: (2020)

How Can We Predict Treatment Outcome for Depression?
por: Walter, Martin, et al.
Publicado: (2014)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

World AIDS Day: together we will stop HIV transmission and conquer AIDS
por: Wainberg, Mark A, et al.
Publicado: (2013)

Commentary: Round and round the mesenchymal stromal cells go; where they stop, we hope to know
por: Matte, Gregory S., et al.
Publicado: (2021)

Can we stop malaria parasites in the skin?
por: Douglas, Ross, et al.
Publicado: (2014)

Do earplugs stop noise from driving critical care patients into delirium?
por: Mills, Gary H, et al.
Publicado: (2012)

The STOP the Bleeding Campaign
por: Rossaint, Rolf, et al.
Publicado: (2013)

Commentary: Because we can
por: Hanna, Waël C.
Publicado: (2020)

Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa
por: Fatti, Geoffrey, et al.
Publicado: (2020)

Preferred antiretroviral drugs for the next decade of scale up
por: Andrieux-Meyer, Isabelle, et al.
Publicado: (2012)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

We need to include bystander first aid in trauma research
por: Bakke, Håkon Kvåle, et al.
Publicado: (2017)

Why we elect narcissists and sociopaths: and how we can stop!
por: Eddy, William A
Publicado: (2019)

Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
por: Ford, Nathan, et al.
Publicado: (2013)

Massive bleeding in polytrauma: how can we make progress?
por: Vincent, Jean-Louis, et al.
Publicado: (2011)

Wrong site surgery! How can we stop it?
por: Hanchanale, Vishwanath, et al.
Publicado: (2014)

The conversation that never stopped
por: Sfard, Anna
Publicado: (2021)

Salamanders and fish can regenerate lost structures - why can't we?
por: Simon, Hans-Georg
Publicado: (2012)

The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
por: Lee, Zelyn, et al.
Publicado: (2021)

Commentary: Just because we can, doesn't always mean we should
por: Nellis, Joseph R., et al.
Publicado: (2021)

How do you circumcise a nation? The Rwandan case study
por: Mutabazi, Vincent, et al.
Publicado: (2014)

Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis
por: Nachega, Jean B, et al.
Publicado: (2015)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

Pharmacy Internships: We Can Do Better
por: Nisly, Sarah, et al.
Publicado: (2018)

GDNF Therapy: Can We Make It Work?
por: Björklund, Anders
Publicado: (2021)

Can we prevent childhood Leukaemia?
por: Greaves, Mel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1kmvtv7e3i19c74ccavl105ruk